» Articles » PMID: 21636845

Systolic Blood Pressure and Incident Heart Failure in the Elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study

Abstract

Background: The exact form of the association between systolic blood pressure (SBP) and heart failure (HF) risk in the elderly remains incompletely defined, especially in individuals not receiving antihypertensive drugs.

Objective: To examine the association between SBP and HF risk in the elderly.

Design: Competing-risks proportional hazards modelling of incident HF risk, using 10-year follow-up data from two NIH-sponsored cohort studies: the Cardiovascular Health Study (inception: 1989-90 and 1992-3) and the Health ABC Study (inception: 1997-8).

Setting: Community-based cohorts.

Participants: 4408 participants (age, 72.8 (4.9) years; 53.1% women, 81.7% white; 18.3% black) without prevalent HF and not receiving antihypertensive drugs at baseline.

Main Outcome Measures: Incident HF, defined as first adjudicated hospitalisation for HF.

Results: Over 10 years, 493 (11.2%) participants developed HF. Prehypertension (120-139 mm Hg), stage 1 (140-159 mm Hg), and stage 2 (≥160 mm Hg) hypertension were associated with escalating HF risk; HRs versus optimal SBP (<120 mm Hg) in competing-risks models controlling for clinical characteristics were 1.63 (95% CI 1.23 to 2.16; p=0.001), 2.21 (95% CI 1.65 to 2.96; p<0.001) and 2.60 (95% CI 1.85 to 3.64; p<0.001), respectively. Overall 255/493 (51.7%) HF events occurred in participants with SBP <140 mm Hg at baseline. Increasing SBP was associated with higher HF risk in women than in men; no race-SBP interaction was seen. In analyses with continuous SBP, HF risk had a continuous positive association with SBP to levels as low as 113 mm Hg in men and 112 mm Hg in women.

Conclusions: There is a continuous positive association between SBP and HF risk in the elderly for levels of SBP as low as <115 mm Hg; over half of incident HF events occur in individuals with SBP <140 mm Hg.

Citing Articles

Association of nighttime very short-term blood pressure variability determined by pulse transit time with adverse prognosis in patients with heart failure.

Sato Y, Yoshihisa A, Ohashi N, Takeishi R, Sekine T, Nishiura K Hypertens Res. 2025; .

PMID: 39833554 DOI: 10.1038/s41440-025-02102-5.


Impact of diabetes mellitus on right ventricular dysfunction and ventricular interdependence in hypertensive patients with heart failure with reduced ejection fraction assessed via 3.0 T cardiac MRI.

Zhang G, Shi R, Li X, Yan W, Xu H, Li Y Cardiovasc Diabetol. 2024; 23(1):375.

PMID: 39443983 PMC: 11515597. DOI: 10.1186/s12933-024-02472-z.


Changing the paradigm in heart failure: shifting from treatment to prevention.

Chang A, Liang Y, Girouard M, Bhatt A, Sandhu A, Sauer A Heart Fail Rev. 2024; 30(1):177-189.

PMID: 39441333 DOI: 10.1007/s10741-024-10454-2.


Noninvasive biometric monitoring technologies for patients with heart failure.

Arriola-Montenegro J, Mutirangura P, Akram H, Tsangaris A, Koukousaki D, Tschida M Heart Fail Rev. 2024; .

PMID: 39436486 DOI: 10.1007/s10741-024-10441-7.


Sex Differences in the Associations of Traditional Risk Factors and Incident Heart Failure Hospitalization: A Prospective Cohort Study of 102 278 Chinese General Adults.

Qiu W, Cai A, Nie Z, Wang J, Ou Y, Feng Y J Am Heart Assoc. 2024; 13(10):e033777.

PMID: 38726897 PMC: 11179797. DOI: 10.1161/JAHA.123.033777.


References
1.
Wolbers M, Koller M, Witteman J, Steyerberg E . Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology. 2009; 20(4):555-61. DOI: 10.1097/EDE.0b013e3181a39056. View

2.
Dunlay S, Weston S, Jacobsen S, Roger V . Risk factors for heart failure: a population-based case-control study. Am J Med. 2009; 122(11):1023-8. PMC: 2789475. DOI: 10.1016/j.amjmed.2009.04.022. View

3.
Ding J, Nicklas B, Fallin M, de Rekeneire N, Kritchevsky S, Pahor M . Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke. Am Heart J. 2006; 152(6):1109-15. DOI: 10.1016/j.ahj.2006.06.021. View

4.
Giamouzis G, Butler J . Relationship between heart failure and lipids: the paradigm continues to evolve. J Card Fail. 2007; 13(4):254-8. DOI: 10.1016/j.cardfail.2007.03.009. View

5.
Britton K, Gaziano J, Djousse L . Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail. 2009; 11(12):1129-34. PMC: 2779833. DOI: 10.1093/eurjhf/hfp141. View